Document is current
Any future updates will be listed below
-
Authors
Hofer, Sebastian J. https://orcid.org/0000-0002-0756-0014
Simon, Anna Katharina
Bergmann, Martina
Eisenberg, Tobias https://orcid.org/0000-0003-3559-1130
Kroemer, Guido https://orcid.org/0000-0002-9334-4405
Madeo, Frank https://orcid.org/0000-0002-5070-1329
- License Information
-
More Information
Article History
Received: 6 April 2022
Accepted: 28 October 2022
First Online: 22 December 2022
Competing interests
: F.M. and G.K. are scientific cofounders of Samsara Therapeutics, a company that develops new pharmacological autophagy inducers. F.M. and T.E. have equity interests in and are advisors of The Longevity Labs (TLL). A.K.S. is consulting for TLL and Oxford Healthspan. G.K. is a scientific cofounder of everImmune, Osasuna Therapeutics and Therafast Bio. G.K. is holding research contracts with Daiichi Sankyo, Eleor, Osasuna Therapeutics, Samsara Therapeutics, Sanofi, Tollys and Vascage. S.J.H. and M.B. declare no competing interests.
